Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose randomized open-label two-way crossover bioequivalence study of ticagrelor 90 mg in healthy Thai volunteers under fasting conditions
TCTR20210302004Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ticagrelor (2 arms), sponsored by International Bio Service. Planned start May 2021; status: not yet recruiting.
02
Drugs
ticagrelor
Beyond the preview
Go deeper on TCTR20210302004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210302004.